Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid ...
The findings of this study can influence societal perspectives on genetic therapies by highlighting a safer alternative to CRISPR–Cas9, as it avoids the risk of generating unintended, potentially ...
Researchers from Japan have established a new in vivo genome-editing system, CRISPR–Cas3, as a promising therapeutic approach for ATTR Genetic disorders occur due to alterations in the primary genetic ...
In a new study, the researchers have shown that the CRISPR–Cas3 system can induce reliable, extensive deletions of the transthyretin (TTR) gene and reduce production of TTR protein without any ...
CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...
CRISPR-Cas is an adaptive immune system of prokaryotes (bacteria and archaea). Apart from protecting its host against invading viruses, alternative biological functions of CRISPR-Cas have also been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results